Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Conditions

Pain 2Neuralgia 2Neoplasms 2Chronic Pain 2Wounds and Injuries 1Peripheral Nervous System Diseases 1Pain, Intractable 1Lymphoma, Follicular 1HIV Infections 1Bronchiolitis Obliterans Syndrome 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Morphine 7Surveys and Questionnaires 6Ketamine 5Fentanyl 4Sodium Chloride 3Saline Solution 3Lidocaine 3Educational Status 3Dexmedetomidine 3Cognitive Behavioral Therapy 3Anesthetics, Local 3ziconotide 2Pregabalin 2Mindfulness-Based Stress Reduction 2Hypnosis 2Control Groups 2Bupivacaine 2Acetaminophen 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tianeptine 1siltuximab 1onabotulinum toxin A 1nabiximols 1morphine, naltrexone combination 1erenumab 1Yoga 1Waiting Lists 1Transcutaneous Electric Nerve Stimulation 1Tramadol 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Chronic Pain × ziconotide × Clear all
NCT07499882 2026-03-30

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

Christian Hospital Northeast Northwest

Not yet recruiting
24 enrolled

Chronic Pain

NCT06541184 2025-02-27

Ziconotide for Non-cancer Pain by Intrathecal Administration

ESTEVE Pharmaceuticals SAS

Recruiting
85 enrolled

Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡